Skip to main content
Hide

For over 40 years, Quest Diagnostics has worked to take what was once rare or highly frictional and make it an accessible, seamless part of cross-clinical patient care. Our Quest Diagnostics Genomics team is dedicated to bridging clinical gaps and simplifying how you deliver advanced care.

Whether at our booth (1177) or poster sessions, let’s discuss how we can support your practice with direct expert access, seamless EMR workflows, and broad coverage that protects your patients. Together, we can make confident genetic insights an accessible reality across your entire care continuum. 

We look forward to connecting with you!


Our genetic counselors will be hosting and speaking in educational sessions at NSGC

Learn from our experts on topics such as

  • Navigating genotype-phenotype counseling
  • Resolving carrier screening ambiguity
  • Clinical utility of fetal diagnostic testing
  • Shifting trends in prenatal testing

 

From in-person to on-demand, see our calendar of sessions below. We can't wait to see you there!

genetics-optum-her

Our educational sessions at NSGC


Our whole exome sequencing delivers

  • Mean read depth of >160x
  • Exome coverage of >98% at 20x
  • Mitochondrial genome results with mean read depth of 6800x
  • Validated CNV evaluation down to 1 exon

 

 

Our pharmacogenomics panels

  • Analyze 21 genes tied to clinically actionable gene-drug associations; Quest-delivered report with genotype (diplotype) and predicted phenotype response
PGx Panel with Coriell Life Sciences
  • Provides access to medication guidance via link to a personalized report powered by InformedDNA®, based on current gene-drug evidence

Upcoming webinar

Sign up here to register for our upcoming webinar, "Harnessing exome to drive earlier diagnoses in pediatric multisystem conditions"

On Wednesday, November 18, join us for an insightful webinar as Emily Partack and Rebecca Johnson explore the critical role of whole exome sequencing (WES). They will share compelling case studies and clinical experiences that show the power of exome testing in action. You will also receive practical, guideline-driven insights to incorporate WES into your workflow.

This webinar covers

  • Evaluating the role of whole exome sequencing in shortening the diagnostic journey 
  • Analyzing patient cases to understand how exome sequencing can identify underlying genetic causes of multisystem conditions in pediatric patients 
  • Translating diagnostic findings from exome sequencing into actionable treatment plans                                                                                                    
  • Exploring ways to leverage exome sequencing clinical guidelines to identify appropriate patients

Podcasts

Listen to the Healthier World podcast episode "Instant Insights: Whole exome sequencing for rare disease"

Rebecca Johnson Wheeler, MS, CGC, explores how whole exome sequencing and Quest Diagnostics genetic experts are transforming rare disease diagnosis by enabling earlier answers, reducing unnecessary testing, and improving care for patients and families.

This podcast covers 

  • A description of whole exome sequencing in rare disease 
  • A review of clinical indications and guidelines for whole exome sequencing, including the available test options
  • An explanation of the role of genetic counselors in supporting rare disease and whole exome sequencing

Listen to the Healthier World podcast episode, "Unlocking answers faster with whole exome sequencing"

Rebecca Johnson Wheeler, MS, CGC, and Steve Keiles, MS, CGC, discuss how advances in WES, growing insurance coverage, and expanding clinical applications are helping patients get answers faster while improving targeted treatment and care.

This podcast covers

  • A review of current trends and guidelines driving increased adoption of whole exome sequencing in clinical practice 
  • A discussion of the potential benefits and limitations of whole exome sequencing including the important components of the test 
  • An explanation of how the clinical interpretation of WES may change over time upon reevaluation as new patient information becomes available
  • An evaluation of how genetic expertise can support clinicians throughout the testing and interpretation process